CRISM Therapeutics Corporation Cash Flow Conversion Efficiency

Latest as of June 2026: -0.574x

CRISM Therapeutics Corporation cash flow conversion efficiency. Based on the latest financial reports, CRISM Therapeutics Corporation (CRTX) has a cash flow conversion efficiency ratio of -0.574x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.48 Million ≈ $-180.19 USD) by net assets (GBX2.58 Million ≈ $313.79 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of CRISM Therapeutics Corporation (2006–2025)

Cash flow conversion efficiency of CRISM Therapeutics Corporation from 2006 to 2025. This chart illustrates how CRISM Therapeutics Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CRTX live share price for real-time trading data and today's change.

CRISM Therapeutics Corporation Cash Flow Conversion Ratio Explained

CRISM Therapeutics Corporation cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

CRISM Therapeutics Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CRISM Therapeutics Corporation ranked by their cash flow conversion efficiency. Also see CRTX market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
GOLDEN SHIELD RESOURCES F:4LE0	N/A
PENTAL LTD F:81B	N/A
INSURAGUEST TECHN. INC. F:4JG	0.216x
Guinness VCT PLC LSE:GVCT	N/A
Tanfield Group PLC LSE:TAN	0.000x
Fusion Antibodies PLC LSE:FAB	-0.792x
Oxurion NV BR:OXUR	0.097x
SEEEN PLC LSE:SEEN	1.594x

Annual Cash Flow Conversion Efficiency for CRISM Therapeutics Corporation (2006–2025)

The table below shows the annual cash flow conversion efficiency of CRISM Therapeutics Corporation from 2006 to 2025. Review CRTX financial flexibility score to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX1.42 Million ≈ $172.29	GBX-1.97 Million ≈ $-239.33	-1.389x	-119.61%
2024-12-31	GBX1.48 Million ≈ $179.46	GBX-933.00K ≈ $-113.52	-0.633x	-117.35%
2023-12-31	GBX-759.66K ≈ $-92.43	GBX-2.77 Million ≈ $-337.03	3.646x	+2499.16%
2022-12-31	GBX23.13 Million ≈ $2.81K	GBX-3.52 Million ≈ $-427.67	-0.152x	-149.67%
2021-12-31	GBX30.11 Million ≈ $3.66K	GBX-1.83 Million ≈ $-223.02	-0.061x	+16.44%
2020-12-31	GBX31.35 Million ≈ $3.81K	GBX-2.28 Million ≈ $-277.87	-0.073x	+21.54%
2019-12-31	GBX20.48 Million ≈ $2.49K	GBX-1.90 Million ≈ $-231.42	-0.093x	+11.24%
2018-12-31	GBX23.48 Million ≈ $2.86K	GBX-2.46 Million ≈ $-298.79	-0.105x	-9.13%
2017-12-31	GBX28.20 Million ≈ $3.43K	GBX-2.70 Million ≈ $-328.88	-0.096x	-22.05%
2016-12-31	GBX25.55 Million ≈ $3.11K	GBX-2.01 Million ≈ $-244.14	-0.079x	+60.09%
2015-12-31	GBX15.21 Million ≈ $1.85K	GBX-2.99 Million ≈ $-364.05	-0.197x	-108.05%
2014-12-31	GBX20.72 Million ≈ $2.52K	GBX-1.96 Million ≈ $-238.43	-0.095x	-5.53%
2013-12-31	GBX18.05 Million ≈ $2.20K	GBX-1.62 Million ≈ $-196.88	-0.090x	-92.36%
2012-12-31	GBX16.12 Million ≈ $1.96K	GBX-750.98K ≈ $-91.37	-0.047x	+63.01%
2011-12-31	GBX21.19 Million ≈ $2.58K	GBX-2.67 Million ≈ $-324.75	-0.126x	-244.69%
2010-12-31	GBX21.29 Million ≈ $2.59K	GBX-778.08K ≈ $-94.67	-0.037x	+28.46%
2009-12-31	GBX16.52 Million ≈ $2.01K	GBX-843.95K ≈ $-102.68	-0.051x	+73.28%
2008-12-31	GBX10.78 Million ≈ $1.31K	GBX-2.06 Million ≈ $-250.79	-0.191x	-80.39%
2007-12-31	GBX6.53 Million ≈ $795.02	GBX-692.47K ≈ $-84.25	-0.106x	+0.92%
2006-12-31	GBX9.33 Million ≈ $1.14K	GBX-998.08K ≈ $-121.44	-0.107x	--

About CRISM Therapeutics Corporation

LSE:CRTX UK Biotechnology

Market Cap

$84.30K

GBX692.87 Million GBX

Market Cap Rank

#31584 Global

#1137 in UK

Share Price

GBX8.75

Change (1 day)

+0.00%

52-Week Range

GBX8.75 - GBX17.50

All Time High

GBX2425.08